BenchSci 's agentic platform can create almost any scientific graph within seconds, including a 3D binding model, tissue expression graph, Forest Plot linking target-to-disease, signaling pathways mapped from literature, and a survival curve from patient data.

BenchSci’s vision is to exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, our platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. We’re a remote-first company recognized for our impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, and Great Place to Work®.